Phase I Trial of Abraxane in Combination With Gemcitabine in Patients With Solid Tumors
Latest Information Update: 12 Apr 2012
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 03 Apr 2012 Actual patient number is 18 according to ClinicalTrials.gov.
- 05 Oct 2008 Actual end date changed to (Oct 2008) added as reported by CT.gov
- 02 Oct 2008 Status changed from active, no longer recruiting to completed as reported by CT.gov